{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:10:16Z","timestamp":1789416616532,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vascn.2022.107225","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:05:27Z","timestamp":1663495527000},"page":"107225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A mouse model of allergic conjunctivitis permitting tear eosinophil quantification"],"prefix":"10.1016","volume":"118","author":[{"given":"Atsushi","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2022.107225_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/mai.2001.117591","article-title":"Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms","volume":"108","author":"Ahluwalia","year":"2001","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0010","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1007\/s00216-016-9624-7","article-title":"Threads for tear film collection and support in quantitative amino acid analysis","volume":"408","author":"Avilov","year":"2016","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.vascn.2022.107225_bb0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: A systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vascn.2022.107225_bb0020","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1067\/mai.2000.110930","article-title":"Tear and conjunctival changes during the allergen-induced early- and late-phase responses","volume":"106","author":"Bacon","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0025","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00417-013-2333-4","article-title":"Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model","volume":"251","author":"Barequet","year":"2013","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.vascn.2022.107225_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00216-018-1488-6","article-title":"Thread-based assay for quantitative small molecule analysis of mice tear fluid by capillary electrophoresis","volume":"411","author":"Barmada","year":"2019","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.vascn.2022.107225_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2019.11.014","article-title":"ICON: Diagnosis and management of allergic conjunctivitis","volume":"124","author":"Bielory","year":"2020","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/ACI.0b013e32830e6b3a","article-title":"Late-phase reaction in ocular allergy","volume":"8","author":"Choi","year":"2008","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0045","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0091-6749(99)70206-X","article-title":"Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage","volume":"103","author":"Fukagawa","year":"1999","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0050","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00417-006-0404-5","article-title":"Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis","volume":"245","author":"Fukushima","year":"2007","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.vascn.2022.107225_bb0055","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1096\/fj.201801805R","article-title":"Dietary \u03c9-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses","volume":"33","author":"Hirakata","year":"2019","journal-title":"FASEB Journal"},{"key":"10.1016\/j.vascn.2022.107225_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00417-011-1695-8","article-title":"B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis","volume":"250","author":"Ishida","year":"2012","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.vascn.2022.107225_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1248\/bpb1978.14.467","article-title":"Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs","volume":"14","author":"Kamei","year":"1991","journal-title":"Journal of Pharmacobio-Dynamics"},{"key":"10.1016\/j.vascn.2022.107225_bb0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/ICO.0b013e3181f23932","article-title":"Rapid immunochromatographic measurement of specific tear immunoglobulin E in moderate to severe cases of allergic conjunctivitis with Immfast check J1 in the spring","volume":"30","author":"Mimura","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.vascn.2022.107225_bb0075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/ICO.0b013e3182000feb","article-title":"Relationship between total tear and serum IgE in allergic conjunctivitis","volume":"30","author":"Mimura","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.vascn.2022.107225_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.28.473","article-title":"Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats","volume":"28","author":"Minami","year":"2005","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.vascn.2022.107225_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergology International"},{"key":"10.1016\/j.vascn.2022.107225_bb0090","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2222.1996.tb00498.x","article-title":"Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge","volume":"26","author":"Montan","year":"1996","journal-title":"Cliincal and Experitnental Allergy"},{"key":"10.1016\/j.vascn.2022.107225_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.02.035","article-title":"Role of histamine H4 receptor in allergic conjunctivitis in mice","volume":"608","author":"Nakano","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2022.107225_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/med-2017-0034","article-title":"Model for studying anti-allergic drugs for allergic conjunctivitis in animals","volume":"12","author":"Nakazawa","year":"2017","journal-title":"Open Medicine"},{"key":"10.1016\/j.vascn.2022.107225_bb0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2009.04010.x","article-title":"Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis","volume":"158","author":"Okano","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0110","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/acsptsci.0c00137","article-title":"Discovery to launch of anti-allergy (Emadine; Patanol\/Pataday\/Pazeo) and anti-glaucoma (Travatan; Simbrinza) ocular drugs, and generation of novel pharmacological tools such as AL-8810","volume":"3","author":"Sharif","year":"2020","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.vascn.2022.107225_bb0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/02713680902866980","article-title":"Cyclosporin a eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction","volume":"34","author":"Shii","year":"2009","journal-title":"Current Eye Research"},{"key":"10.1016\/j.vascn.2022.107225_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10384-004-0187-3","article-title":"Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB\/c mice","volume":"49","author":"Shoji","year":"2005","journal-title":"Japanese Journal of Ophthalmology"},{"key":"10.1016\/j.vascn.2022.107225_bb0125","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0130","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0091-6749(96)70204-X","article-title":"Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure","volume":"97","author":"Tomassini","year":"1996","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.vascn.2022.107225_bb0135","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3565(25)24478-0","article-title":"Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen","volume":"272","author":"Woodward","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:05:52Z","timestamp":1761005152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":27,"alternative-id":["S1056871922000727"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107225","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mouse model of allergic conjunctivitis permitting tear eosinophil quantification","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107225"}}